The treated cardiomyocytes also showed elevated levels of BNP, a clinical marker of heart failure, a reduction in CX43 expression and downregulation of several calcium handling and ion channel related genes, changes commonly observed in the failing heart29 (Fig. 4B, C, Supplementary Fig. 4A, B). The gene discussed is NPPB; the disease is heart failure.